A conceptual framework for analysing and planning synthetic approaches to diverse lead-like scaffolds.

Historically, chemists' exploration of chemical space has been exceptionally uneven and unsystematic. This feature article outlines a comprehensive conceptual framework that may be used to capture, analyse and plan synthetic approaches that may address this historically uneven exploration. Illustrative examples of synthetic approaches that target, or have potential to target, broad tracts of lead-like chemical space are presented within the context of this conceptual framework. Particular emphasis is placed on synthetic approaches that enable the combinatorial variation of molecular scaffold, particularly within the boundaries of lead-like chemical space.

[1]  Allan M Jordan,et al.  The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. , 2011, Journal of medicinal chemistry.

[2]  David R Spring,et al.  Two-directional synthesis as a tool for diversity-oriented synthesis: Synthesis of alkaloid scaffolds , 2012, Beilstein journal of organic chemistry.

[3]  Channa K. Hattotuwagama,et al.  Lead-oriented synthesis: a new opportunity for synthetic chemistry. , 2012, Angewandte Chemie.

[4]  Danielle M. Schultz,et al.  Palladium-catalyzed alkene carboamination reactions for the synthesis of substituted piperazines. , 2009, Tetrahedron.

[5]  Stefan Wetzel,et al.  Interactive exploration of chemical space with Scaffold Hunter. , 2009, Nature chemical biology.

[6]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[7]  Adam Nelson,et al.  Iridium‐Catalyzed Asymmetric Allylic Amination with Polar Amines: Access to Building Blocks with Lead‐Like Molecular Properties , 2010 .

[8]  G. Hammond,et al.  Highly efficient Cu(I)-catalyzed synthesis of N-heterocycles through a cyclization-triggered addition of alkynes. , 2010, Journal of the American Chemical Society.

[9]  P. Svensson,et al.  Stereocontrolled access to optically-enriched oxabispidines. , 2012, Chemical communications.

[10]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.

[11]  Nathan T. Ross,et al.  An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. , 2010, Journal of the American Chemical Society.

[12]  Y. Nelyubina,et al.  Synthesis of PDE IVb Inhibitors. 3. Synthesis of (+)-, (-)-, and (±)-7-[3-(cyclopentyloxy)-4-methoxyphenyl]hexahydro-3H-pyrrolizin-3-one via reductive domino transformations of 3-β-carbomethoxyethyl-substituted six-membered cyclic nitronates. , 2012, The Journal of organic chemistry.

[13]  A. H. Lipkus,et al.  Structural Diversity of Organic Chemistry. a Scaffold Analysis of the Cas Registry , 2022 .

[14]  Stefan Wetzel,et al.  Bioactivity-guided mapping and navigation of chemical space. , 2009, Nature chemical biology.

[15]  Bong Young Chung,et al.  Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers. , 2006, Bioorganic & medicinal chemistry letters.

[16]  Francesco Marchetti,et al.  Towards the systematic exploration of chemical space. , 2012, Organic & biomolecular chemistry.

[17]  Alan Rolfe,et al.  Formal [4+3] epoxide cascade reaction via a complementary ambiphilic pairing strategy. , 2010, Organic letters.

[18]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[19]  Matthew W D Perry,et al.  Spiro-fused pyrrolidine, piperidine, and oxindole scaffolds from lactams. , 2012, Organic letters.

[20]  Adam Nelson,et al.  Convergent, regiospecific synthesis of quinolines from o-aminophenylboronates. , 2008, Organic letters.

[21]  Stefan Wetzel,et al.  Biology-oriented synthesis. , 2011, Angewandte Chemie.

[22]  John P Wolfe,et al.  New strategy for the synthesis of substituted morpholines. , 2009, The Journal of organic chemistry.

[23]  John P Wolfe,et al.  Mild conditions for the synthesis of functionalized pyrrolidines via Pd-catalyzed carboamination reactions. , 2007, Organic letters.

[24]  E. J. Sorensen,et al.  Palladium-catalyzed ring-forming aminoacetoxylation of alkenes. , 2005, Journal of the American Chemical Society.

[25]  Artis Klapars,et al.  Synthesis of medium ring nitrogen heterocycles via a tandem copper-catalyzed C-N bond formation-ring-expansion process. , 2004, Journal of the American Chemical Society.

[26]  Leonie Campbell,et al.  A Au(i)-catalyzed N-acyl iminium ion cyclization cascade. , 2007, Journal of the American Chemical Society.

[27]  P. Leeson,et al.  A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.

[28]  György M. Keserü,et al.  The influence of lead discovery strategies on the properties of drug candidates , 2009, Nature Reviews Drug Discovery.

[29]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[30]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[31]  David R Spring,et al.  Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. , 2010, Nature communications.

[32]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[33]  Stuart L Schreiber,et al.  Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.

[34]  Simon J F Macdonald,et al.  Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.

[35]  Spiros Liras,et al.  An efficient synthesis of bridged heterocycles from an Ir(I) bis-amination/ring-closing metathesis sequence. , 2012, Organic letters.

[36]  Jürgen Bajorath,et al.  Lessons Learned from Molecular Scaffold Analysis , 2011, J. Chem. Inf. Model..

[37]  Stefano Nicolai,et al.  Pd(0)-catalyzed oxy- and aminoalkynylation of olefins for the synthesis of tetrahydrofurans and pyrrolidines. , 2011, Organic letters.

[38]  Christopher Hulme,et al.  The solution phase synthesis of diketopiperazine libraries via the Ugi reaction: Novel application of Armstrong's convertible isonitrile. , 1998 .

[39]  D. Dixon,et al.  Nitro-Mannich/lactamization cascades for the direct stereoselective synthesis of pyrrolidin-2-ones. , 2009, Organic letters.

[40]  William Lewis,et al.  Synthesis of natural-product-like scaffolds in unprecedented efficiency via a 12-fold branching pathway , 2011 .

[41]  Didier Rognan,et al.  Assessing the Scaffold Diversity of Screening Libraries , 2006, J. Chem. Inf. Model..

[42]  Stuart L Schreiber,et al.  A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.

[43]  Irini Akritopoulou-Zanze,et al.  Isocyanide-based multicomponent reactions in drug discovery. , 2008, Current opinion in chemical biology.

[44]  Christopher Hulme,et al.  NOVEL APPLICATIONS OF ETHYL GLYOXALATE WITH THE UGI MCR , 1999 .

[45]  J. Bajorath,et al.  Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. , 2010, Journal of medicinal chemistry.

[46]  Eelco Ruijter,et al.  Multicomponent reaction design in the quest for molecular complexity and diversity. , 2011, Angewandte Chemie.

[47]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[48]  A. Kalogirou,et al.  Stereoselective synthesis of densely functionalized pyrrolidin-2-ones by a conjugate addition/nitro-Mannich/lactamization reaction. , 2012, The Journal of organic chemistry.

[49]  W. Marsden.  I and J , 2012 .

[50]  Danielle M Schultz,et al.  Intramolecular alkene carboamination reactions for the synthesis of enantiomerically enriched tropane derivatives. , 2011, Organic letters.

[51]  Adam Nelson,et al.  Synthesis of Natural-Product-Like Molecules with Over Eighty Distinct Scaffolds** , 2008, Angewandte Chemie.

[52]  Adam Nelson,et al.  Convergent synthesis of dihydroquinolones from o-aminoarylboronates , 2009 .

[53]  Jingyao Zhou,et al.  Multicomponent approach in the synthesis of 2,2,6-trisubstituted morpholine derivatives. , 2012, Organic letters.

[54]  J. Wolfe,et al.  Selective synthesis of 5- or 6-aryl octahydrocyclopenta[b]pyrroles from a common precursor through control of competing pathways in a Pd-catalyzed reaction. , 2005, Journal of the American Chemical Society.

[55]  Anang A Shelat,et al.  Scaffold composition and biological relevance of screening libraries. , 2007, Nature chemical biology.

[56]  G. Keum,et al.  An efficient synthesis of morpholin-2-one derivatives using glycolaldehyde dimer by the Ugi multicomponent reaction. , 2001, Organic letters.

[57]  J. Wolfe,et al.  Mild conditions for Pd-catalyzed carboamination of N-protected hex-4-enylamines and 1-, 3-, and 4-substituted pent-4-enylamines. Scope, limitations, and mechanism of pyrrolidine formation. , 2008, The Journal of organic chemistry.

[58]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..